Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
News
james_caggiano

Targazyme snaps up new CEO

September 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
Appointment
fda_21_0

FDA approves GlaxoSmithKline’s Trelegy for treating asthma

September 10, 2020 Research and Development Ashtma, inhaler

The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca Chief Executive says vaccine is still possible this year

September 10, 2020 Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …
News
800px-rhesus_macaque_monkey_the_look

Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine

September 10, 2020 Research and Development COVID, Macaques, Monkey, Vaccine

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …
News
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
Appointment
1

Ali Fattaey appointed Chief Executive Officer of MetaboMed

September 9, 2020 Research and Development

MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …
Appointment
alexion_sign

Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds

September 9, 2020 Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland

The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …
News

AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness

September 9, 2020 Research and Development AstraZeneca, COVID-19, pharma

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
News
800px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

Gatherings of over six people to be banned in England from Monday

September 9, 2020 Research and Development Lockdown, coronavirus

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.  Currently, most outdoor gatherings …
News
download_1

Roche to start new trials of Ocrevus to defend multiple sclerosis franchise

September 9, 2020 Research and Development MS, MS drug, Roche

Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
News
china_v_0_1

Major vaccine manufacturers sign COVID-19 safety pledge

September 9, 2020 Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine

Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19.  The companies involved …
News
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Appointment
sanofi_hq__boetie_hall_web

Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma

September 8, 2020 Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma

New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026